463 related articles for article (PubMed ID: 17188764)
41. Antibodies elicited by the secretions from schistosome cercariae and eggs are predominantly against glycan epitopes.
Kariuki TM; Farah IO; Wilson RA; Coulson PS
Parasite Immunol; 2008 Oct; 30(10):554-62. PubMed ID: 18786069
[TBL] [Abstract][Full Text] [Related]
42. Targeted glycoproteomic analysis reveals that kappa-5 is a major, uniquely glycosylated component of Schistosoma mansoni egg antigens.
Meevissen MH; Balog CI; Koeleman CA; Doenhoff MJ; Schramm G; Haas H; Deelder AM; Wuhrer M; Hokke CH
Mol Cell Proteomics; 2011 May; 10(5):M110.005710. PubMed ID: 21372247
[TBL] [Abstract][Full Text] [Related]
43. IPSE/alpha-1: a major immunogenic component secreted from Schistosoma mansoni eggs.
Schramm G; Gronow A; Knobloch J; Wippersteg V; Grevelding CG; Galle J; Fuller H; Stanley RG; Chiodini PL; Haas H; Doenhoff MJ
Mol Biochem Parasitol; 2006 May; 147(1):9-19. PubMed ID: 16480783
[TBL] [Abstract][Full Text] [Related]
44. Saposin-like proteins are expressed in the gastrodermis of Schistosoma mansoni and are immunogenic in natural infections.
Don TA; Bethony JM; Loukas A
Int J Infect Dis; 2008 Nov; 12(6):e39-47. PubMed ID: 18571965
[TBL] [Abstract][Full Text] [Related]
45. Differential expression of LacdiNAc, fucosylated LacdiNAc, and Lewis x glycan antigens in intramolluscan stages of Schistosoma mansoni.
Nyame AK; Yoshino TP; Cummings RD
J Parasitol; 2002 Oct; 88(5):890-7. PubMed ID: 12435126
[TBL] [Abstract][Full Text] [Related]
46. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc beta 1-4(Fuc alpha 1-2Fuc alpha 1-3)GlcNAc.
Van der Kleij D; Van Remoortere A; Schuitemaker JH; Kapsenberg ML; Deelder AM; Tielens AG; Hokke CH; Yazdanbakhsh M
J Infect Dis; 2002 Feb; 185(4):531-9. PubMed ID: 11865406
[TBL] [Abstract][Full Text] [Related]
47. Specific antibody responses to three schistosome-related carbohydrate structures in recently exposed immigrants and established residents in an area of Schistosoma mansoni endemicity.
Naus CW; van Remoortere A; Ouma JH; Kimani G; Dunne DW; Kamerling JP; Deelder AM; Hokke CH
Infect Immun; 2003 Oct; 71(10):5676-81. PubMed ID: 14500488
[TBL] [Abstract][Full Text] [Related]
48. Characterization of developmentally regulated epitopes of Schistosoma mansoni egg glycoprotein antigens.
Weiss JB; Strand M
J Immunol; 1985 Aug; 135(2):1421-9. PubMed ID: 2409151
[TBL] [Abstract][Full Text] [Related]
49. Schistosoma mansoni shares a protective oligosaccharide epitope with freshwater and marine snails.
Dissous C; Grzych JM; Capron A
Nature; 1986 Oct 2-8; 323(6087):443-5. PubMed ID: 2429191
[TBL] [Abstract][Full Text] [Related]
50. Serodiagnosis of human intestinal schistosomiasis.
Raouf EA; Shousha WG; Mahdy el-SM; Maklad SS
Egypt J Immunol; 2007; 14(1):55-62. PubMed ID: 18689281
[TBL] [Abstract][Full Text] [Related]
51. Schistosoma haematobium and Schistosomiasis mansoni: production of an estradiol-related compound detected by ELISA.
Botelho MC; Crespo M; Almeida A; Vieira P; Delgado ML; Araujo L; Machado JC; Correia da Costa JM
Exp Parasitol; 2009 Jul; 122(3):250-3. PubMed ID: 19361503
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis of schistosomiasis mansoni: an evaluation of existing methods and research towards single worm pair detection.
Ogongo P; Kariuki TM; Wilson RA
Parasitology; 2018 Sep; 145(11):1355-1366. PubMed ID: 29506583
[TBL] [Abstract][Full Text] [Related]
53. Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine.
Kariuki TM; Van Dam GJ; Deelder AM; Farah IO; Yole DS; Wilson RA; Coulson PS
Infect Immun; 2006 Jul; 74(7):3979-86. PubMed ID: 16790771
[TBL] [Abstract][Full Text] [Related]
54. Schistosoma mansoni and Schistosoma haematobium: identification and characterization of glycoconjugate antigens in the hemolymph of infected vector snails.
Schmitt J; Wuhrer M; Hamburger J; Jourdane J; Ramzy RM; Geyer R; Ruppel A
J Parasitol; 2002 Jun; 88(3):505-13. PubMed ID: 12099419
[TBL] [Abstract][Full Text] [Related]
55. Determination of the specificity of monoclonal antibodies against Schistosoma mansoni CAA glycoprotein antigen using neoglycoconjugate variants.
Carvalho de Souza A; van Remoortere A; Hokke CH; Deelder AM; Vliegenthart JF; Kamerling JP
Biol Chem; 2005 Sep; 386(9):901-8. PubMed ID: 16164415
[TBL] [Abstract][Full Text] [Related]
56. Schistosoma mansoni: the egg, biosynthesis of the shell and interaction with the host.
deWalick S; Tielens AG; van Hellemond JJ
Exp Parasitol; 2012 Sep; 132(1):7-13. PubMed ID: 21840309
[TBL] [Abstract][Full Text] [Related]
57. Glycomic Analysis of Life Stages of the Human Parasite Schistosoma mansoni Reveals Developmental Expression Profiles of Functional and Antigenic Glycan Motifs.
Smit CH; van Diepen A; Nguyen DL; Wuhrer M; Hoffmann KF; Deelder AM; Hokke CH
Mol Cell Proteomics; 2015 Jul; 14(7):1750-69. PubMed ID: 25883177
[TBL] [Abstract][Full Text] [Related]
58. Characterization of a series of novel fucose-containing glycosphingolipid immunogens from eggs of Schistosoma mansoni.
Levery SB; Weiss JB; Salyan ME; Roberts CE; Hakomori S; Magnani JL; Strand M
J Biol Chem; 1992 Mar; 267(8):5542-51. PubMed ID: 1544929
[TBL] [Abstract][Full Text] [Related]
59. Molecular characterisation of kappa-5, a major antigenic glycoprotein from Schistosoma mansoni eggs.
Schramm G; Hamilton JV; Balog CI; Wuhrer M; Gronow A; Beckmann S; Wippersteg V; Grevelding CG; Goldmann T; Weber E; Brattig NW; Deelder AM; Dunne DW; Hokke CH; Haas H; Doenhoff MJ
Mol Biochem Parasitol; 2009 Jul; 166(1):4-14. PubMed ID: 19428667
[TBL] [Abstract][Full Text] [Related]
60. IgA antibodies to a protective antigen in human Schistosomiasis mansoni.
Grzych JM; Grezel D; Xu CB; Neyrinck JL; Capron M; Ouma JH; Butterworth AE; Capron A
J Immunol; 1993 Jan; 150(2):527-35. PubMed ID: 8419485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
